199P Suppression of mutant Kirsten-RAS (KRAS G12C) non-small cell lung cancer (NSCLC) resistance to KRAS G12C inhibitors by dual inhibition of hepatocyte growth factor receptor (MET) and V-ATPase
作者
Rafael Rosell,Jose Luis Gomez-Vazquez,Eloisa Jantus Lewintre,M. Ito,P. Cao,Xueting Cai,B. Xing,Silvia Calabuig Fariñas,A.F. Cardona,J.K. Rodríguez,M. Marco Jordán,Carlos Pedraz‐Valdunciel,Miguel A. Molina‐Vila,J. Codony-Servat,Z. Dantes,A. Aguilar,Ivana Sullivan,Irene Moya Horno,L. Cirera,M. Gonzalez-Cao